Skip to main content
ADCES26 Main banner
Visit TZIELD at Booth #1510 (Sanofi Ad)

Cardiometabolic Conditions and Treatment Options

(M03) Navigating Post-transplantation Diabetes: Integrating Management and Care Models

Monday, August 10, 2026
8:00 AM - 8:45 AM ET
CE: .75 CE
Pharmacology Hours: .25 CE
Post-transplantation diabetes mellitus (PTDM) is a significant complication following solid organ transplantation, influencing long-term health and outcomes. This session provides a practical, evidence-based framework for identifying and managing PTDM, grounded in the latest international consensus. The presenter will review definitions, risk factors, diagnostic and prognostic strategies, then explore management across the continuum—from early postoperative hyperglycemia to long-term care. Novel agents such as GLP-1 receptor agonists and SGLT2 inhibitors will be discussed in the context of transplant-specific considerations, alongside lifestyle interventions and diabetes technology. The session concludes with a case-based example of an integrated endocrinology service within a kidney transplant clinic, highlighting interprofessional collaboration and person-centered care.

Learning Objectives:

At the completion of this activity, participants should be able to:
  • Explain the definitions, risk factors, and diagnostic strategies for post-transplantation diabetes mellitus (PTDM).
  • Apply evidence-based management approaches for PTDM across the continuum of care, incorporating pharmacologic options, lifestyle strategies, and diabetes technology.
  • Analyze an interprofessional care model within a kidney transplant clinic to identify roles and responsibilities that optimize person-centered glycemic management.
Disclosure(s):
KEVIN MALLOY, PharmD, BCPS, BC-ADM, CDCES: Sanofi: Consultant / Advisory Board (Ongoing), Speaker (Contract) (Ongoing)
Logan Hunkus, PharmD: No financial relationships to disclose